Menu Search
Equities

Sipai Health Technology Co, Ltd

314:HKG.HS

Sipai Health Technology Co, Ltd

Actions
  • Price (HKD)5.18
  • Today's Change-0.02 / -0.38%
  • Shares traded284.60k
  • 1 Year change-40.66%
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sipai Health Technology Co Ltd is principally engaged in providing medical and health services. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.

  • Revenue in HKD (TTM)5.08bn
  • Net income in HKD-264.54m
  • Incorporated2015
  • Employees3.25k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.